Tumor Proliferative Fraction in Solid Malignant Neoplasms A Comparative Study of Ki-67 Immunostaining and Flow Cytometric Determinations
Authors:
- Jae Y. RoJRJae Y. Ro
- Adel K. El-NaggarAEAdel K. El-Naggar
- Patricia L. WilsonPWPatricia L. Wilson
- Kim TeagueKTKim Teague
- Mark BlickMBMark Blick
- Alberto G. AyalaAAAlberto G. Ayala
Open Access
- 1 October 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 96 (4) , 512-519
Abstract
Tumor proliferative fraction (TPF) has been shown to correlate with prognosis in some malignancies. A method for its determination that is practical, accurate, and reproducible is still being sought. In this comparative study of techniques, TPF values were determined in mirror-image samples of 126 consecutive solid malignant neoplasms using flow cytometry and immunostaining with Ki-67, a monoclonal antibody that recognizes an unknown nuclear antigen expressed during the entire cell proliferation cycle but not in resting cells. The mean TPF values for all cases were 19.5 ± 15.6% (percentage of tumor cells stained) by Ki-67 (range, 1-86%) and 15.7 ± 9.6% (S + G2M) by flow cytometry (range, 3-60%), which correlated significantly at r = 0.53 and P = 0.005. (≤;10%, r = 0.28) than in tumors with intermediate and high Sphase values (r = 0.66). Ki-67 staining percentages did not correlate with patient age, sex, or tissue origin of the tumor. Ki-67 staining appears comparable to flow cytometry determination of TPF in solid malignancies with intermediate and high S-phase values. In tumors with low S-phase values, Ki-67 immunostaining shows higher TPF values, which perhaps reflect an increase in the proportion of G1-phase cells or dilutional effect of nonneoplastic cells in the tumors with low proliferative fraction.Keywords
This publication has 30 references indexed in Scilit:
- DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinomaCancer, 1990
- The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumorsCancer, 1990
- Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic countCancer, 1990
- Flow cytometry using paraffin‐embedded tissue: Five years onCytometry, 1989
- Relationship between labeling indices of KI-67 and brdurd in human malignant tumorsCancer, 1988
- Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breastCancer, 1987
- A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancersCancer, 1986
- Prediction of early course of breast carcinoma by thymidine labelingCancer, 1983
- S-phase fractions of colorectal carcinomas related to pathologic and clinical featuresCancer, 1981
- A method of labeling tissues with tritiated thymidine in vitro and its use in comparing rates of cell proliferation in duct epithelium, fibroadenoma, and carcinoma of human breastCancer, 1961